Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia

Article

关键词: INITIATING CELL-ACTIVITY;    ACUTE MYELOID-LEUKEMIA;    H3K27 DEMETHYLASE;    EXPRESSION PROFILES;    JMJD3 CONTRIBUTES;    STEM-CELL;    UTX;    MUTATIONS;    ACTIVATION;    GENOME;   

DOI  :  10.1038/nature13605

来源: SCIE

【 摘 要 】

T-cell acute lymphoblastic leukaemia (T-ALL) is a haematological malignancy with a dismal overall prognosis, including a relapse rate of up to 25%, mainly because of the lack of non-cytotoxic targeted therapy options. Drugs that target the function of key epigenetic factors have been approved in the context of haematopoietic disorders(1), and mutations that affect chromatin modulators in a variety of leukaemias have recently been identified(2,3); however, epigenetic drugs are not currently used for T-ALL treatment. Recently, we described that the polycomb repressive complex 2 (PRC2) has a tumour-suppressor role in T-ALL(4). Here we delineated the role of the histone 3 lysine 27 (H3K27) demethylases JMJD3 and UTX in T-ALL. We show that JMJD3 is essential for the initiation and maintenance of T-ALL, as it controls important oncogenic gene targets by modulating H3K27 methylation. By contrast, we found that UTX functions as a tumour suppressor and is frequently genetically inactivated in T-ALL. Moreover, we demonstrated that the small molecule inhibitor GSKJ4 (ref. 5) affects T-ALL growth, by targeting JMJD3 activity. These findings show that two proteins with a similar enzymatic function can have opposing roles in the context of the same disease, paving the way for treating haematopoietic malignancies with a new category of epigenetic inhibitors.

【 授权许可】

Free